Zenas BioPharma (ZBIO) Treasury Shares (2023 - 2026)

Zenas BioPharma's Treasury Shares history runs 4 years deep, the most recent figure standing at $667600.0 for Q1 2026.

• In Q1 2026, Treasury Shares changed N/A year-over-year to $667600.0; the TTM figure through Mar 2026 stood at $667600.0 (changed N/A YoY), while the FY2025 annual figure was $599675.0, up 2732.4% from the prior year.
• Treasury Shares was $667600.0 for Q1 2026 at Zenas BioPharma, up from $599675.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $667600.0 in Q1 2026 to a low of $21172.0 in Q1 2024.
• Historically, Treasury Shares has averaged $339038.4 across 4 years, with a median of $511100.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares decreased 22.16% in 2024, then surged 2732.4% in 2025.
• A 4-year view of Treasury Shares shows it stood at $27200.0 in 2023, then dropped by 22.16% to $21172.0 in 2024, then soared by 2732.4% to $599675.0 in 2025, then gained by 11.33% to $667600.0 in 2026.
• The last three Treasury Shares figures came in at $667600.0 (Q1 2026), $599675.0 (Q4 2025), and $525350.0 (Q3 2025), per Business Quant data.